Share

Meta-Analysis Of The Efficacy Of Sildenafil (ViagraTM) In The Treatment Of Severe Erectile Dysfunction

This meta-analysis involved studies on a total of 3,361 men who had severe erectile dysfunction (ED). Of this group, 60% involved males with organic ED, 15% had psychogenic problems, and 25% had mixed difficulties. Data were merged from 10 double-blind, placebo-controlled, fixed dose or flexible dose studies.

Over an 8-week period, patients took sildenafil or placebo, as needed, 1 hour prior to sexual activity. The frequency of penetration and the frequency of maintained erections was assessed at baseline and at week 8 using the 15-item self-administered International Index of Erectile Function. Responses were from 0 (did not attempt intercourse) or 1 (almost never/never) to 5 (almost always/always). Severe ED was defined as a baseline score of 0 or 1.

In this analysis, responders were defined as patients who had a score greater than 4 or those whose final score increased by greater than 1. Of 819 men on sildenafil, 377 (46%) had a score greater than 4 on penetration and 393 (48%) had a score greater than 4 on maintaining an erection. Placebo responders averaged 8%. Responders who had a final score increase greater than 1 averaged from 71% to 73%.

According to the investigator, the results of this meta- analysis of sildenafil at 50 and 100 mg doses show it is effective in men with severe ED.

Share

AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.